title: Port-A-Cath infection causes inhibitor recurrence after initial successful ITI.
authors: G
authors: G
authors: Grangl
authors: S
authors: S
authors: Gallistl
authors: B
authors: B
authors: Leschnik
authors: W
authors: W
authors: Muntean
mesh_terms: D001424:Bacterial Infections / Q000209:etiology* / Q000382:microbiology; D019774:Blood Coagulation Factor Inhibitors / Q000097:blood*; D002675:Child, Preschool; D004926:Escherichia coli / Q000302:isolation & purification; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000627:therapeutic use; D015942:Factor VIIa / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D008297:Male; D020636:Pantoea / Q000302:isolation & purification; D011994:Recombinant Proteins / Q000627:therapeutic use; D012008:Recurrence; D062666:Vascular Access Devices / Q000009:adverse effects*; D014841:von Willebrand Factor / Q000627:therapeutic use
chemical_list: D019774:Blood Coagulation Factor Inhibitors; D011994:Recombinant Proteins; D014841:von Willebrand Factor; D005169:Factor VIII; C103587:recombinant FVIIa; D015942:Factor VIIa